Results 111 to 120 of about 4,424 (197)

Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial

open access: yes
The Cambridge Centre for Myelin Repair One (CCMR-One) trial showed that 6 months of bexarotene reduces visual evoked potential (VEP) latency in people with relapsing-remitting multiple sclerosis (MS).

core   +1 more source

Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment.

open access: yes, 1985
In fourteen subjects with various stages of hepatic encephalopathy (HE), Visual Evoked Potential (VEP) recording and blood ammonia (NH3), octopamine (OCT) and phenylethanolamine (PEA) determinations were performed before and during a four-day treatment ...
Ferri R   +5 more
core  

Magnetoencephalography biomarkers for assessing myelin content and neuronal function in acute optic neuritis. [PDF]

open access: yesBrain Commun
Beigneux Y   +13 more
europepmc   +1 more source

Study of the cholinergic factors affecting the flash and pattern reversal visual evoked potentials [PDF]

open access: yes
The effects of cholinergic agents undergoing clinical trials for the treatment of Alzheimer's disease and the anticholinergic agent scopolamine, were investigated on the components of the flash and pattern reversal visual evoked potentials (VEPs) in ...
Padhiar, Sanjita
core  

ELECTROPHYSIOLOGICAL (EEG, BAEP, VEP) STUDY IN PATIENTS WITH BETA-THALASSEMIA MAJOR

open access: yes, 1987
Twenty-four patients affected by beta-thalassemia major were studied by means of combined EEG, VEP and BAEP recordings. All the subjects were treated with regular blood transfusions and chelating therapy (DFO). An elevated incidence of EEG abnormalities (
MOROCUTTI, Cristoforo   +7 more
core  

Home - About - Disclaimer - Privacy